Application of serum 48-lncRNA as a diagnostic marker for chronic liver diseases
A chronic disease and liver technology, applied in the field of diagnostic targets for chronic liver diseases, can solve the problems of limited accuracy in the diagnosis and differential diagnosis of chronic liver diseases, and the lack of clinical application.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0022] The inventor first extracted 109 serum samples from the training group (including 23 normal (HC) people, 30 chronic hepatitis B (CHB) patients, 30 liver cirrhosis (LC) patients, and 26 liver cancer (HCC) patients) 181 samples were selected between normal people and patients (including patients with chronic hepatitis B, liver cirrhosis and liver cancer) through chip scanning, data extraction, and data standardization processing. lncRNAs whose expression fold change is greater than 1.5 and p<0.001. Next, the inventors used Fisher discriminant analysis (stepwise regression method) to screen the 181 differentially expressed lncRNAs, and signed a set of molecular labels composed of 48 lncRNAs. The results showed that this label can 100% distinguish between normal and chronic B Hepatitis, cirrhosis and liver cancer.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


